1
|
Choschzick I, Hirseland E, Cramer H, Schultz S, Leppert J, Tronnier V, Zechel C. Responsiveness of stem-like human glioma cells to all-trans retinoic acid and requirement of retinoic acid receptor isotypes α, β and γ. Neuroscience 2014; 279:44-64. [PMID: 25171789 DOI: 10.1016/j.neuroscience.2014.07.078] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2014] [Revised: 07/01/2014] [Accepted: 07/30/2014] [Indexed: 01/12/2023]
Abstract
Retinoic acid (RA) is required for development and homeostasis of the normal mammalian brain and may play a role in the initiation and progression of malignant brain tumors, such as the glioblastoma multiforme (GBM) and the gliosarcoma (Gsarc). The subpopulation of stem-like glioma cells (SLGCs) was shown to resist standard glioma radio-/chemotherapy and to propagate tumor regrowth. We used phenotypically distinct, self-renewing SLGC lines from six human GBMs, two Gsarcs, and two subcloned SLGC derivatives in order to investigate their responsiveness to all-trans retinoic acid (atRA) and to identify the RA-receptor (RAR) isotypes involved. In general, atRA exerted a pro-proliferative and pro-survival effect on SLGCs, though the efficacy was distinct. By means of RAR isotype-selective retinoids we disclosed that these effects were mediated by RARα and RARγ, except for one SLGC line, in which the pro-proliferative signal was induced by the RARβ-selective retinoid. Only one GBM-derived cell line (T1338) and a subpopulation of another (T1389) displayed neural differentiation in response to atRA. Differentiation of T1338 was induced by RARα and RARγ isotype-selective retinoids, associated with down-regulation of Sox2, and the failure to induce orthotopic tumors in the brains of SCID mice. The differential responsiveness of the SLGC lines appeared unrelated to the expression of RARβ, as (i) atRA augmented RAR isotype mRNA expression and particularly rarβ mRNA in all SLGC lines, (ii) rarβ promoter hypomethylation in the SLGC lines was not related to differentiation and (iii) the induction of T1338 differentiation was by RARα- and RARγ-selective ligands.
Collapse
Affiliation(s)
- I Choschzick
- Department of Neurosurgery, University of Lübeck, D-23538 Lübeck, Germany
| | - E Hirseland
- Department of Neurosurgery, University of Lübeck, D-23538 Lübeck, Germany; Department of Radiation Oncology, University of Lübeck, D-23538 Lübeck, Germany
| | - H Cramer
- Department of Neurosurgery, University of Lübeck, D-23538 Lübeck, Germany
| | - S Schultz
- Department of Neurosurgery, University of Lübeck, D-23538 Lübeck, Germany; Department of Radiation Oncology, University of Lübeck, D-23538 Lübeck, Germany
| | - J Leppert
- Department of Neurosurgery, University of Lübeck, D-23538 Lübeck, Germany
| | - V Tronnier
- Department of Neurosurgery, University of Lübeck, D-23538 Lübeck, Germany
| | - C Zechel
- Department of Neurosurgery, University of Lübeck, D-23538 Lübeck, Germany.
| |
Collapse
|
2
|
Choschzick I, Frahm L, Leppert J, Loy M, Kerstein A, Willkomm S, Varatharajan R, Tronnier V, Zechel C. Heterogeneity of stem-like human glioma cells. J Stem Cells Regen Med 2010; 6:140. [PMID: 24693148] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Affiliation(s)
- I Choschzick
- Universität zu Lübeck, Neurochirurgie , Lübeck, Germany
| | - L Frahm
- Universität zu Lübeck, Neurochirurgie , Lübeck, Germany
| | - J Leppert
- Universität zu Lübeck, Neurochirurgie , Lübeck, Germany
| | - M Loy
- Universität zu Lübeck, Neurochirurgie , Lübeck, Germany
| | - A Kerstein
- Universität zu Lübeck, Neurochirurgie , Lübeck, Germany
| | - S Willkomm
- Universität zu Lübeck, Neurochirurgie , Lübeck, Germany
| | | | - V Tronnier
- Universität zu Lübeck, Neurochirurgie , Lübeck, Germany
| | - C Zechel
- Universität zu Lübeck, Neurochirurgie , Lübeck, Germany
| |
Collapse
|
3
|
Willkomm S, Bernt A, Ueck C, Choschzick I, Tronnier V, Zechel C. Proliferative capacity of stem-like human glioma cells. J Stem Cells Regen Med 2010; 6:141. [PMID: 24693149] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Affiliation(s)
- S Willkomm
- Universität zu Lübeck, Neurochirurgie , Lübeck, Germany
| | - A Bernt
- Universität zu Lübeck, Neurochirurgie , Lübeck, Germany
| | - C Ueck
- Universität zu Lübeck, Neurochirurgie , Lübeck, Germany
| | - I Choschzick
- Universität zu Lübeck, Neurochirurgie , Lübeck, Germany
| | - V Tronnier
- Universität zu Lübeck, Neurochirurgie , Lübeck, Germany
| | - C Zechel
- Universität zu Lübeck, Neurochirurgie , Lübeck, Germany
| |
Collapse
|
4
|
Kerstein A, Leppert J, Gödecke L, Bähr L, Pawlak E, Tronnier V, Zechel C. Therapy responsiveness of stem-like human glioma cells. J Stem Cells Regen Med 2010; 6:142. [PMID: 24693150] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Affiliation(s)
- A Kerstein
- Universitätsklinikum Schleswig-Holstein, Klinik für Neurochirurgie , Lübeck, Germany
| | - J Leppert
- Universitätsklinikum Schleswig-Holstein, Klinik für Neurochirurgie , Lübeck, Germany
| | - L Gödecke
- Universitätsklinikum Schleswig-Holstein, Klinik für Neurochirurgie , Lübeck, Germany
| | - L Bähr
- Universitätsklinikum Schleswig-Holstein, Klinik für Neurochirurgie , Lübeck, Germany
| | - E Pawlak
- Universitätsklinikum Schleswig-Holstein, Klinik für Neurochirurgie , Lübeck, Germany
| | - V Tronnier
- Universitätsklinikum Schleswig-Holstein, Klinik für Neurochirurgie , Lübeck, Germany
| | - C Zechel
- Universitätsklinikum Schleswig-Holstein, Klinik für Neurochirurgie , Lübeck, Germany
| |
Collapse
|
5
|
Kerstein A, Choschzick I, Tronnier V, Zechel C. Stem-like human glioma cells. J Stem Cells Regen Med 2010; 6:137. [PMID: 24693145] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Affiliation(s)
- A Kerstein
- Universitätsklinikum Schleswig-Holstein, Klinik für Neurochirurgie , Lübeck, Germany
| | - I Choschzick
- Universitätsklinikum Schleswig-Holstein, Klinik für Neurochirurgie , Lübeck, Germany
| | - V Tronnier
- Universitätsklinikum Schleswig-Holstein, Klinik für Neurochirurgie , Lübeck, Germany
| | - C Zechel
- Universitätsklinikum Schleswig-Holstein, Klinik für Neurochirurgie , Lübeck, Germany
| |
Collapse
|
6
|
Tiede S, Danner S, Tronnier V, Paus R, Zechel C. Human dermis-derived cells demonstrate strong features of controlled mesodermal differentiation. J Stem Cells Regen Med 2007; 2:137-138. [PMID: 24692956] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Affiliation(s)
- S Tiede
- Department of Dermatology, Allergology and Venerology, UK-SH, Campus Lubeck , Lubeck, Germany
| | - S Danner
- IBMT, Fraunhofer-Institute , Lubeck, Germany
| | - V Tronnier
- Department of Neurosurgery, UH-SH, Campus Lubeck , Lubeck, Germany
| | - R Paus
- Department of Dermatology, Allergology and Venerology, UK-SH, Campus Lubeck , Lubeck, Germany
| | - C Zechel
- Department of Neurosurgery, UH-SH, Campus Lubeck , Lubeck, Germany
| |
Collapse
|
7
|
Zechel C, Moeckel S, Stoerchel P, Pawlak E, Tronnier V. Influence of growth factors, neurotrophic factors and proteins of the extracellular matrix on expansion and differentiation of adult neural stem cells. J Stem Cells Regen Med 2007; 2:198-199. [PMID: 24692997] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Affiliation(s)
- C Zechel
- Universitaetsklinikum Schleswig-Holstein Campus Luebeck, Department of Neurosurgery , Ratzeburger Allee 160, 23538 Luebeck, Germany
| | - S Moeckel
- Universitaetsklinikum Schleswig-Holstein Campus Luebeck, Department of Neurosurgery , Ratzeburger Allee 160, 23538 Luebeck, Germany
| | - P Stoerchel
- Universitaetsklinikum Schleswig-Holstein Campus Luebeck, Department of Neurosurgery , Ratzeburger Allee 160, 23538 Luebeck, Germany
| | - E Pawlak
- Universitaetsklinikum Schleswig-Holstein Campus Luebeck, Department of Neurosurgery , Ratzeburger Allee 160, 23538 Luebeck, Germany
| | - V Tronnier
- Universitaetsklinikum Schleswig-Holstein Campus Luebeck, Department of Neurosurgery , Ratzeburger Allee 160, 23538 Luebeck, Germany
| |
Collapse
|
8
|
Tiede S, Danner S, Tronnier V, Paus R, Zechel C. Human dermis-derived cells demonstrate strong features of controlled mesodermal differentiation. J Stem Cells Regen Med 2007; 2:129. [PMID: 24692948] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Affiliation(s)
- S Tiede
- Department of Dermatology, Allergology and Venerology, UK-SH, Campus Lubeck , Lubeck, Germany
| | - S Danner
- IBMT, Fraunhofer-Institute , Lubeck, Germany
| | - V Tronnier
- Department of Neurosurgery, UH-SH, Campus Lubeck , Lubeck, Germany
| | - R Paus
- Department of Dermatology, Allergology and Venerology, UK-SH, Campus Lubeck , Lubeck, Germany
| | - C Zechel
- Department of Neurosurgery, UH-SH, Campus Lubeck , Lubeck, Germany
| |
Collapse
|
9
|
Junker R, Brandt B, Semjonow A, Erren M, Zechel C, Assmann G. The biologic lower detection limit of six ultrasensitive PSA assays. Anticancer Res 1999; 19:2625-8. [PMID: 10470206] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/13/2023]
Abstract
BACKGROUND The benefit of monitoring patients with prostate cancer (PCA) by ultrasensitive measurement of prostate specific antigen (PSA) is frequently discussed. Usually, the analytic lower detection limit of an ultrasensitive assay is determined by the manufacturer. As the analytic lower detection limit does not take into account interfering factors of human serum, the biologic lower detection limit, which is defined as PSA concentration detected in PSA-free human serum, plus 3 standard deviations, is of greater interest. MATERIALS AND METHODS We investigated the biologic lower detection limit of six ultrasensitive PSA assays. Sera from 15 men with bladder cancer after radical cystoprostatectomy and from 30 healthy women were applied. Hence, we expected no PSA of prostatic origin. RESULTS The biologic lower detection limit obtained using these sera was up to 30 fold higher (men, 0.29-0.63 ng/ml; women, 0.03-0.69 ng/ml) than the analytic lower detection limit (0.01-0.09 ng/ml). CONCLUSIONS PSA measurement in sera obtained from men without prostate and women results in PSA values above the ultrasensitive range. Therefore, advantages provided by ultrasensitive PSA measurement in monitoring PCA patients after radical prostatectomy are limited.
Collapse
Affiliation(s)
- R Junker
- Institut für Klinische Chemie und Laboratoriumsmedizin, Westfälische Wilhelms-Universität Münster, Germany.
| | | | | | | | | | | |
Collapse
|
10
|
Eng FC, Barsalou A, Akutsu N, Mercier I, Zechel C, Mader S, White JH. Different classes of coactivators recognize distinct but overlapping binding sites on the estrogen receptor ligand binding domain. J Biol Chem 1998; 273:28371-7. [PMID: 9774463 DOI: 10.1074/jbc.273.43.28371] [Citation(s) in RCA: 56] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
We have analyzed interaction of coactivators with the wild-type estrogen receptor alpha (ER), HEG0, and a mutant, L536P-HEG0, which is constitutively active in several transiently transfected cells and a HeLa line that stably propagates an estrogen-sensitive reporter gene. Different classes of coactivators do not recognize the ER ligand binding domain (LBD) in the same manner. Steroid receptor coactivator-1 (SRC-1), amplified in breast cancer-1 (AIB-1), transcriptional intermediary factor-1 (TIF-1), transcriptional intermediary factor-2 (TIF-2), and receptor interacting protein 140 (RIP140) interacted with HEG0 and L536P-HEG0 in the presence of estradiol, but generally not in the presence of anti-estrogens. However, ICI164,384 stimulated some interaction of RIP140 with LBDs. SRC-1, AIB-1, and RIP140 interacted constitutively with the L536P ER, whereas TIF-1 and TIF-2 interacted only weakly in the absence of hormone. Reciprocal competition for binding to the ER LBD was observed between different classes of coactivators. Moreover, coexpression of RIP140 blocked enhanced transactivation by HEG0 observed in the presence of TIF-2, suggesting that RIP140 may play a negative role in ER signaling. We conclude that constitutive activity of L536P-HEG0 is manifested to similar degrees in different cell types and likely arises from constitutive coactivator binding; different classes of coactivators recognize distinct but overlapping binding sites on the ER LBD. Finally, the observation that L536P-HEG0 interacted constitutively with AIB-1, a coactivator that has been implicated in ER signaling in breast and ovarian cancer, suggests that similar mutations in the ER may contribute to hormone-independent proliferation of breast and ovarian cells.
Collapse
Affiliation(s)
- F C Eng
- Departments of Physiology and Medicine, McGill University, Montréal H3G 1Y6, Canada
| | | | | | | | | | | | | |
Collapse
|
11
|
Vivat V, Zechel C, Wurtz JM, Bourguet W, Kagechika H, Umemiya H, Shudo K, Moras D, Gronemeyer H, Chambon P. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers. EMBO J 1997; 16:5697-709. [PMID: 9312028 PMCID: PMC1170201 DOI: 10.1093/emboj/16.18.5697] [Citation(s) in RCA: 110] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023] Open
Abstract
Mutations of a single residue in the retinoid X receptor alpha (RXRalpha) ligand-binding pocket (LBP) generate constitutive, ligand-binding-competent mutants with structural and functional characteristics similar to those of agonist-bound wild-type RXR. Modelling of the mouse RXRalphaF318A LBP suggests that, like agonist binding, the mutation disrupts a cluster of van der Waals interactions that maintains helix H11 in the apo-receptor location, thereby shifting the thermodynamic equilibrium to the holo form. Heterodimerization with some apo-receptors (retinoic acid, thyroid hormone and vitamin D3 receptors) results in 'silencing' of RXRalphaF318A constitutive activity, which, on the other hand, efficiently contributes to synergistic transactivation within NGFI-B-RXR heterodimers. RAR mutants disabled for corepressor binding and/or lacking a functional AF-2 activation domain, do not relieve RXR 'silencing'. Not only RAR agonists, but also the RAR antagonist BMS614 induce conformational changes allowing RXR to exert constitutive (RXRalphaF318A) or agonist-induced (wild-type RXR) activity in heterodimers. Interestingly, the RXRalphaF318A constitutive activity generated within heterodimers in the presence of BMS614 requires the integrity of both RXR and RAR AF-2 domains. These observations suggest that, within RXR-RAR heterodimers, RAR can adopt a structure distinct from that of the active holo-RAR, thus allowing RXR to become transcriptionally responsive to agonists.
Collapse
MESH Headings
- Allosteric Regulation
- Amino Acid Sequence
- Amino Acid Substitution
- Animals
- Binding Sites
- DNA-Binding Proteins/chemistry
- DNA-Binding Proteins/metabolism
- Dimerization
- Humans
- Ligands
- Mice
- Models, Structural
- Mutagenesis, Site-Directed
- Nuclear Receptor Subfamily 4, Group A, Member 1
- Protein Conformation/drug effects
- Protein Multimerization
- Receptors, Cytoplasmic and Nuclear
- Receptors, Retinoic Acid/antagonists & inhibitors
- Receptors, Retinoic Acid/chemistry
- Receptors, Retinoic Acid/metabolism
- Receptors, Steroid/chemistry
- Receptors, Steroid/metabolism
- Recombinant Proteins/chemistry
- Recombinant Proteins/metabolism
- Retinoid X Receptors
- Retinoids/pharmacology
- Transcription Factors/chemistry
- Transcription Factors/metabolism
- Transfection
- Tretinoin/pharmacology
Collapse
Affiliation(s)
- V Vivat
- Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC)/CNRS/INSERM/ULP/Collège de France, BP 163, 67404 Illkrich Cedex, CU de Strasbourg, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Junker R, Brandt B, Zechel C, Assmann G. Comparison of prostate-specific antigen (PSA) measured by four combinations of free PSA and total PSA assays. Clin Chem 1997; 43:1588-94. [PMID: 9299938] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
We compared prostate-specific antigen (PSA) assay systems [i.e., free PSA (f-PSA) and the corresponding total PSA (t-PSA) assay] from four different manufacturers as well as the f-PSA/t-PSA ratios with regard to their ability to discriminate between benign prostate hyperplasia (BPH) and prostate cancer (PCA). ROC analysis showed similar areas under the curves (AUCs) with different assay systems. For the entire patient population the AUCs of the f-PSA/t-PSA ratio were not or slightly increased compared with the sole measurement of t-PSA (t-PSA, 0.792-0.820; f-PSA/t-PSA ratio, 0.685-0.859). In contrast, for only those patients who showed t-PSA concentrations within the diagnostic gray area of 4-25 micrograms/L t-PSA, the AUCs were greater for the f-PSA/ t-PSA ratio than for measurement of t-PSA alone (t-PSA, 0.608-0.647; f-PSA/t-PSA ratio, 0.690-0.806). These results were confirmed by the predictive values of the negative results (NPVs) of the t-PSA assays and the f-PSA/t-PSA ratios (assay thresholds corresponding to a 95% detection limit). Compared with the sole t-PSA measurement there was no mentionable increase in the NPVs due to the f-PSA/t-PSA ratio for the entire patient population, but an increase up to 49% when limited to t-PSA concentrations within 4-25 micrograms/L. We therefore conclude that the f-PSA/t-PSA ratio may be helpful for differential diagnosis of BPH and PCA within the diagnostic gray area of 4-25 micrograms/L t-PSA.
Collapse
Affiliation(s)
- R Junker
- Institut für Klinische Chemie und Laboratoriumsmedizin, Westfälische Wilhelms-Universität Münster, Germany
| | | | | | | |
Collapse
|
13
|
Semjonow A, Oberpenning F, Brandt B, Zechel C, Brandau W, Hertle L. Impact of free prostate-specific antigen on discordant measurement results of assays for total prostate-specific antigen. Urology 1996; 48:10-5. [PMID: 8973694 DOI: 10.1016/s0090-4295(96)00604-8] [Citation(s) in RCA: 36] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
OBJECTIVES To determine why various assays for total PSA (t-PSA) produce discordant results in identical serum samples. METHODS A total of 84 sera from 40 patients with histologically confirmed benign prostatic hyperplasia and from 44 patients with untreated prostate cancer were analyzed with seven assays for t-PSA and the Hybritech research assay for free prostate-specific antigen (f-PSA). Comparison between assays was performed by linear regression of the t-PSA concentrations as well as between the t-PSA concentrations and the f/t-PSA ratios. RESULTS The coefficients of correlation for the investigated assays versus Hybritech Tandem-E range from 0.96 to 0.99. Nevertheless average PSA concentrations differed significantly from the Tandem-E assay in all assays. Despite a good correlation, some assays showed a regression line with a slope notably different from 1. In these assays, elevated concentrations were observed in sera with a high proportion of f-PSA. CONCLUSIONS The study illustrates a significant and clinically relevant discordance between reported t-PSA concentrations for identical samples, depending on the assay used and on the contents of f-PSA in the sample. The interpretation of t-PSA concentrations requires awareness of the applied assay as well as the establishment of an assay-specific reference range in order to avoid inappropriate clinical consequences, such as unnecessary biopsies. Respective details must be contained in the laboratory reports. A change of assays without specifically reassessing previously valid reference ranges or the uncritical use of a customarily applied limit of < 4 ng/mL will otherwise be harmful to the patient.
Collapse
Affiliation(s)
- A Semjonow
- Westfälische Wilhelms-Universität, Münster, Germany
| | | | | | | | | | | |
Collapse
|
14
|
Voegel JJ, Heine MJ, Zechel C, Chambon P, Gronemeyer H. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J 1996; 15:3667-75. [PMID: 8670870 PMCID: PMC452006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023] Open
Abstract
Nuclear receptors (NRs) act as ligand-inducible transcription factors which regulate the expression of target genes upon binding to cognate response elements. The ligand-dependent activity of the NR activation function AF-2 is believed to be mediated to the transcription machinery through transcriptional mediators/intermediary factors (TIFs). We report here the cloning of the 160 kDa human nuclear protein TIF2, which exhibits all properties expected for a mediator of AF-2: (i) it interacts in vivo with NRs in an agonist-dependent manner; (ii) it binds directly to the ligand-binding domains (LBDs) of NRs in an agonist- and AF-2-integrity-dependent manner in vitro; (iii) it harbours an autonomous transcriptional activation function; (iv) it relieves nuclear receptor autosquelching; and (v) it enhances the activity of some nuclear receptor AF-2s when overexpressed in mammalian cells. TIF2 exhibits partial sequence homology with the recently isolated steroid receptor coactivator SRC-1, indicating the existence of a novel gene family of nuclear receptor transcriptional mediators.
Collapse
Affiliation(s)
- J J Voegel
- Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), CNRS/INSERM/ULP/Collége de France, Illkrich, Strasbourg, France
| | | | | | | | | |
Collapse
|
15
|
Voegel JJ, Heine MJ, Zechel C, Chambon P, Gronemeyer H. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J 1996. [DOI: 10.1002/j.1460-2075.1996.tb00736.x] [Citation(s) in RCA: 806] [Impact Index Per Article: 28.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
16
|
Le Douarin B, vom Baur E, Zechel C, Heery D, Heine M, Vivat V, Gronemeyer H, Losson R, Chambon P. Ligand-dependent interaction of nuclear receptors with potential transcriptional intermediary factors (mediators). Philos Trans R Soc Lond B Biol Sci 1996; 351:569-78. [PMID: 8735280 DOI: 10.1098/rstb.1996.0056] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023] Open
Abstract
The activity of the ligand-inducible activation function 2 (AF-2) contained in the ligand binding domain (LBD) of nuclear receptors (NRs) is thought to be mediated by transcriptional intermediary factors (TIFs). We have recently reported the isolation and characterization of two novel mouse proteins, designated TIF1 and mSUG1, that interact in a ligand-dependent fashion with the LBD (region E) of several NRs in vivo as well as in vitro. Remarkably, these interactions require the conserved core motif of the AF-2 activating domain (AF-2 AD) and can be blocked by AF-2 antagonists. TIF1 and mSUG1 might therefore represent TIFs/mediators for the ligand-dependent AF-2 of NRs. By comparing the interaction properties of these two putative TIFs with different NRs including the oestrogen (ER), thyroid hormone (TR), vitamin D3 (VDR), retinoic acid (RAR alpha) and retinoid X (RXR) receptors, we demonstrate that: (i) RXR alpha efficiently interacts with TIF1, but not with mSUG1, whereas TR alpha interacts much more efficiently with mSUG1 than with TIF1, and RAR alpha, VDR and ER efficiently interact with both TIF1 and mSUG1; (ii) the amphipathic alpha helix core of AF-2 AD is differentially involved in the interactions of RAR alpha with TIF1 and mSUG1; and (iii) the AF-2 AD cores of RAR alpha and ER are similarly involved in their interaction with TIF1, but not with mSUG1. Thus the interaction interfaces between the various NRs and either TIF1 or mSUG1 may vary depending on the nature of both the receptor and the putative mediator of its AF-2 function. We discuss the possible roles of TIF1 and mSUG1 as mediators of the transcriptional activity of the AF-2 of NRs.
Collapse
Affiliation(s)
- B Le Douarin
- Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/ULP, Collège de France, Illkirch, France
| | | | | | | | | | | | | | | | | |
Collapse
|
17
|
vom Baur E, Zechel C, Heery D, Heine MJ, Garnier JM, Vivat V, Le Douarin B, Gronemeyer H, Chambon P, Losson R. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J 1996. [DOI: 10.1002/j.1460-2075.1996.tb00339.x] [Citation(s) in RCA: 279] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
18
|
vom Baur E, Zechel C, Heery D, Heine MJ, Garnier JM, Vivat V, Le Douarin B, Gronemeyer H, Chambon P, Losson R. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J 1996; 15:110-24. [PMID: 8598193 PMCID: PMC449923] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023] Open
Abstract
Using a yeast two-hybrid system we report the isolation of a novel mouse protein, mSUG1, that interacts with retinoic acid receptor alpha (RAR alpha) both in yeast cells and in vitro in a ligand- and AF-2 activating domain (AF-2 AD)-dependent manner and show that it is a structural and functional homologue of the essential yeast protein SUG1. mSUG1 also efficiently interacts with other nuclear receptors, including oestrogen (ER), thyroid hormone (TR), Vitamin D3 (VDR) and retinoid X (RXR) receptors. By comparing the interaction properties of these receptors with mSUG1 and TIF1, we demonstrate that: (i) RXR alpha efficiently interacts with TIF1, but not with mSUG1, whereas TR alpha interacts much more efficiently with mSUG1 than with TIF1, and RAR alpha, VDR and ER efficiently interact with mSUG1 and TIF1; (ii) the amphipathic alpha-helix core of the AF-2 AD is differentially involved in interactions of RAR alpha with mSUG1 and TIF1; (iii) the AF-2 AD cores of RAR alpha and ER are similarly involved in their interaction with TIF1, but not with mSUG1. Thus, the interaction interfaces between the different receptors and either mSUG1 or TIF1 may vary depending on the nature of the receptor and the putative mediator of its AF-2 function. We discuss the possibility that mSUG1 and TIF1 may mediate the transcriptional activity of the AF-2 of nuclear receptors through different mechanisms.
Collapse
Affiliation(s)
- E vom Baur
- Institut de Génétique et de Biologie Moleculaire et Cellulaire, CNRS/INSERM/ULP, Collège de France, Cedex, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Le Douarin B, Zechel C, Garnier JM, Lutz Y, Tora L, Pierrat P, Heery D, Gronemeyer H, Chambon P, Losson R. The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J 1995; 14:2020-33. [PMID: 7744009 PMCID: PMC398302 DOI: 10.1002/j.1460-2075.1995.tb07194.x] [Citation(s) in RCA: 434] [Impact Index Per Article: 15.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Nuclear receptors (NRs) bound to response elements mediate the effects of cognate ligands on gene expression. Their ligand-dependent activation function, AF-2, presumably acts on the basal transcription machinery through intermediary proteins/mediators. We have isolated a mouse nuclear protein, TIF1, which enhances RXR and RAR AF-2 in yeast and interacts in a ligand-dependent manner with several NRs in yeast and mammalian cells, as well as in vitro. Remarkably, these interactions require the amino acids constituting the AF-2 activating domain conserved in all active NRs. Moreover, the oestrogen receptor (ER) AF-2 antagonist hydroxytamoxifen cannot promote ER-TIF1 interaction. We propose that TIF1, which contains several conserved domains found in transcriptional regulatory proteins, is a mediator of ligand-dependent AF-2. Interestingly, the TIF1 N-terminal moiety is fused to B-raf in the mouse oncoprotein T18.
Collapse
Affiliation(s)
- B Le Douarin
- Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/ULP, Collège de France, Illkirch, Strasbourg
| | | | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Zechel C, Shen XQ, Chen JY, Chen ZP, Chambon P, Gronemeyer H. The dimerization interfaces formed between the DNA binding domains of RXR, RAR and TR determine the binding specificity and polarity of the full-length receptors to direct repeats. EMBO J 1994; 13:1425-33. [PMID: 8137826 PMCID: PMC394960 DOI: 10.1002/j.1460-2075.1994.tb06396.x] [Citation(s) in RCA: 174] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
Abstract
Heterodimers of retinoid X receptor (RXR) and retinoic acid receptor (RAR) bind preferentially to directly repeated elements with spacing of two (DR2) or five (DR5) base pairs, due to the specific heterocooperative interaction of their DNA binding domains (DBDs) on these elements. We have demonstrated in the accompanying paper that the heterodimeric DBD interface that is responsible for the cooperative binding to DR5 elements, specifically involves the D-box of the RXR CII finger and the tip of the RAR CI finger. We show here that a second type of dimerization interface, which specifically implicates the RAR T-box and the RXR CII finger to the exclusion of the D-box, determines the selective binding to DR2 elements. Interestingly, the same type of dimerization interface (RXR T-box and CII finger) is responsible for the cooperative binding of homodimers of the RXR DBD to DR1 elements. Based on the three-dimensional structure of the glucocorticoid receptor DBD, modeling of RXR/RAR, RXR/TR and RXR/RXR DBD cooperative interactions predicts that in all cases the DBD contributing the CII finger, i.e. that of RXR, has to be positioned 5' to its cooperatively bound partner. This binding polarity of the DBDs is conferred upon the full-length receptors, since crosslinking experiments indicate that RXR is always 5' to RAR in complexes between either DR5 or DR2 and RXR/RAR heterodimers. The possible significance of these observations for transactivation by retinoic acid receptors is discussed.
Collapse
Affiliation(s)
- C Zechel
- Laboratoire de Génétique Moléculaire des Eucaryotes du CNRS et Unité 184 de Biologie Moléculaire et de Génie Génétique de l'INSERM, Faculté de Médecine, Strasbourg, France
| | | | | | | | | | | |
Collapse
|
21
|
Zechel C, Shen XQ, Chambon P, Gronemeyer H. Dimerization interfaces formed between the DNA binding domains determine the cooperative binding of RXR/RAR and RXR/TR heterodimers to DR5 and DR4 elements. EMBO J 1994; 13:1414-24. [PMID: 8137825 PMCID: PMC394959 DOI: 10.1002/j.1460-2075.1994.tb06395.x] [Citation(s) in RCA: 137] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
We have previously reported that the binding site repertoires of heterodimers formed between retinoid X receptor (RXR) and either retinoic acid receptor (RAR) or thyroid hormone receptor (TR) bound to response elements consisting of directly repeated PuG(G/T)TCA motifs spaced by 1-5 bp [direct repeat (DR) elements 1-5] are highly similar to those of their corresponding DNA binding domains (DBDs). We have now mapped the dimerization surfaces located in the DBDs of RXR, RAR and TR, which are responsible for cooperative interaction on DR4 (RXR and TR) and DR5 (RXR and RAR). The D-box of the C-terminal CII finger of RXR provides one of the surfaces which is specifically required for the formation of the heterodimerization interfaces on both DR4 and DR5. Heterodimerization with the RXR DBD on DR5 specifically requires the tip of the RAR CI finger as the complementary surface, while a 7 amino acid sequence encompassing the 'prefinger region', but not the TR CI finger, is specifically required for efficient dimerization of TR and RXR DBDs on DR4. Importantly, DBD swapping experiments demonstrate not only that the binding site repertoires of the full-length receptors are dictated by those of their DBDs, but also that the formation of distinct dimerization interfaces between the DBDs are the critical determinants for cooperative DNA binding of these receptors to specific DRs.
Collapse
Affiliation(s)
- C Zechel
- Laboratoire de Génétique Moléculaire des Eucaryotes du CNRS et Unité 184 de Biologie Moléculaire et de Génie Génétique de l'INSERM, Faculté de Médecine, Strasbourg, France
| | | | | | | |
Collapse
|
22
|
Zechel C, Peters H, Schleenbecker U, Anders F. Expression of genes related to the human erbB, erbA, pdgf and pdgf-r in tumors of different etiology in Xiphophorus. Int J Cancer 1992; 52:66-75. [PMID: 1323541 DOI: 10.1002/ijc.2910520114] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
The melanoma determining Tu locus of the teleost Xiphophorus contains an accessory gene, x-erbB*a, which is closely related to the EGF receptor gene family, and is probably oncogenic. x-erbB*a exists in allelic forms that are specific for distinct Tu-loci, and shows high homology to a non-allelic non-oncogenic counterpart x-erbB*i which is transcribed into mRNA of 4.6 kb in non-tumorous and tumorous tissues of fish harboring and lacking Tu. Expression of a 4.0-kb mRNA in tumors (melanoma and fibrosarcoma) of different etiology is strictly correlated with the inheritance of X. maculatus x-erbB*a alleles; transcripts of 8.0 kb were detected in melanoma and carcinoma of fish harboring a certain x-erbB*a of X. variatus. The expression of the putative x-erbB*a transcripts parallels the stage of malignancy of the tumor. The expression of the xiphophorine EGF receptor gene (x-erbB) was detected in almost all tumors, is strongly enhanced in carcinoma, and is positively correlated with the degree of malignancy of melanoma and fibrosarcoma. Some tumors show expression of erbA-related genes. The PDGF receptor mRNA is expressed in all tumors analyzed and shows enhanced expression in malignant tumors of neurogenic, epithelial and mesenchymal origin. Expression of x-pdgf was observed in several cases of melanoma, but more frequently in carcinoma and fibrosarcoma. We conclude that x-erbB*a might be involved in initiation of tumors of different cellular origin and etiology in fish harboring Tu, as well as in the determination of the malignancy of the tumor. Furthermore, we assume that x-erbB*i, x-erbB, x-pdgf and x-pdgf-r play a role in secondary events in tumorigenesis by, e.g., conferring a selective growth advantage to the tumor cells.
Collapse
Affiliation(s)
- C Zechel
- Genetisches Institut, Justus Liebig-Universität, Giessen, Germany
| | | | | | | |
Collapse
|
23
|
Anders F, Anders A, Zechel C. A gene alone may not make a tumor. AIDS Res Hum Retroviruses 1992; 8:833-53. [PMID: 1515234] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022] Open
Affiliation(s)
- F Anders
- Justus Liebig-University, Genetics Institute, Giessen, Germany
| | | | | |
Collapse
|
24
|
Barrett JC, Afshari CA, Annab LA, Burkhart BA, Boyd JA, Owen RD, Futreal PA, Richter KH, Moses HL, Lavker RM, Miller S, Sun TT, Stingl G, Bianchi AB, Navone NM, Conti CJ, Spencer JM, Kahn S, Weinstein IB, Silvers DS, DeLeo VA, Larcher F, Bauluz C, Quintanilla M, Ballestin C, Jorcano JL, Schön M, Haas M, Klein CE, Weber L, Cerri A, Tadini G, Gitto R, Berti E, Cano A, Caulín C, Gómez M, Gandarillas A, Martín M, Montes A, Navarro P, Bastian BC, Van der Piepen U, Römisch J, Pâques E, Hartmann AA, Krieg P, Schnapke R, Feil S, Fürstenberger G, Marks F, Missero C, Cajal SRY, Filvaroff E, Dotto GP, Sherman J, Albert RE, Baxter CS, Bauer G, Höfler P, Götschl M, Viesel E, Jürgensmeier J, Schaefer D, Picht G, Grande T, Real A, Rünqer TM, Möller K, Fuchs P, Bauer C, Epe' B, Gruner S, Diezel W, Macejewski J, Weber H, Eckert R, Volk HD, Sönnichsen N, Bavinck JNB, Vermeer BJ, Van Der Woude FJ, Vandenbroucke JP, Claas FHJ, Griffin EF, Harris H, Tilgen W, Garbe C, Østerlind A, Weiss J, Jung EG, Ruiter DJ, Danen E, Broecker EB, Johnson JP, van Muijen GNP, Halaban R, Krüger-Krasagakes S, Orfanos CE, Newton JA, Bataille V, Cuzick J, Bishop T, Schwaaf A, Azizi E, Bröcker EB, Eberlein B, Froschermaier S, Gollhausen R, Przybilla B, Krasagakis K, Abdel-Naser MB, Lopez-Bran E, Robledo A, Lopez-Bran E, Heine H, Hennig B, Graf G, Nährig J, Niedner R, Schöpf E, Mailhammer R, Reisbach G, Kempkes B, Hültner L, Thalmeier K, Anders F, Zechel C, Schleenbecker U, Leers J, Smith A, Wagner E, Burcin U, Hug H, Fiebich B, Anders A, Gröger H, Schlatterer B, Moll I, Wollina U, Leigh IM, Purkis PE, Markey A, Neill S, Proby C, Glover M, Lane EB, Klein-Szanto AJP, Yaar M, Garmyn M, Gilani A, Gilchrest BA, Bowden GT, Nelson M, Levy J, Tanooka H, Ootsuyama A, Urbach F, van der Leun JC, de Gruijl FR, Kripke ML, Yuspa SH, Glick A, Lee E, Diugosz A, Balmain A, Bums P, Kemp CJ, Stoler AB, Harks F, Boukamp P, Pascheberg U, Breitkreutz D, Hülsen A, Altmeier S, Tomakidi P, Fusenig NE, Lowy DR, Sedman SA, Cohen BD, Schiller JT, Kricker A, Armstrong BK, English D, Heenan PJ, Randell PL, de Gruijl FR, Kelfkens G, van Weelden H, van der Leun JC, Grabbe S, Bruvers S, Granstein RD, Albert R, Miller M, Cody T, Baxter C, Shukla R, Ueda M, Ichihashi M, Yamamura K, Hayashibe K, Funasaka Y, Mishima Y, Fujiwara Y, Ichihashi M, Jimbo T, Mishima Y, Popanda O, Thielmann HW, Jahrens D, Edler L, Ootsuyama A, Tanooka H, Sutter C, Mukhtar H, Strickland PT, Winter H, Schweizer J, Schmidt R, Weber E, Rippmann F, Hecker E, Kopp-Schneider A, Lehmann WD, Stephan M, Troll W, Wei H, Fujiki H, Garte SJ, Frenkel K, Svetek J, Schara M, Pečar S, Hergenhahn M, Kinzel V, Richards J, Plein P, Schiess K, Kaszkin M, Yamamoto S, Wang JC, Kato R, Kuroki T, Hashimoto Y, Osada S, Ohno S, Gilles C, Piette M, Foidart JM, Ranki A, Lassus J, Lehmus A, Niemi KM, Friesel H, Schneider T, Steinbauer B, Sorg B, Winter A, Krauter G, Krauß R, Roeser H, Unger S, Janiaud P, Rueß D, Mechler BM, Stanbridge EJ, Gross MM, Buček M, Klein-Bauernschmitt P, Schlehofer JR, Kosters R, Stark HJ, Okulov VB, Elgjo K, Ushmorov AG, Danilov AO, Zubova SG, Furstenberger G, Faissner A. Supplement II: Abstracts of the international symposium on Skin Carcinogenesis in man and in experimental models. Heidelberg, 29–31 October 1991 (pp S61–S88). J Cancer Res Clin Oncol 1991. [DOI: 10.1007/bf01613300] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
25
|
Abstract
This paper reports the synthesis and the biological activities of six new glucagon analogues. In these compounds N-terminal modifications of the glucagon sequence were made, in most cases combined with changes in the C-terminal region which had been shown previously to enhance receptor affinity. The design of these analogues was based on [Lys17,18,Glu21]glucagon,1 a superagonist, which binds five times better than glucagon to the glucagon receptor, and on the potent glucagon antagonist [D-Phe4,Tyr5,Arg12]glucagon, which does not stimulate adenylate cyclase system even at very high concentrations. The N-terminal modifications involved substitution of His1 by the unnatural conformationally constrained residue, 4,5,6,7-tetrahydro-1H-imidazo[c]pyridine-6-carboxylic acid (Tip) and by desaminohistidine (dHis). In addition we prepared two analogues (6 and 7), in which we deleted the Phe6 residue, which was suggested to be part of a hydrophobic patch and involved in receptor binding. The following compounds were synthesized: [Tip1, Lys17,18,Glu21]glucagon (2); [Tip1,D-Phe4,Tyr5,Arg12,Lys17,18,Glu21]glucagon (3); [dHis1,D-Phe4,Tyr5,Arg12,Lys17,18,Glu21]glucagon (4); [dHis1,Asp3,D-Phe4,Tyr5,Arg12,Lys17,18,Glu21+ ++]glucagon (5); des-Phe6-[Tip1,D-Phe4,Tyr5,Arg12,Glu21]glucagon (6); des-Phe6-[Asp3,D-Phe4,Tyr5,Arg12,Glu21]glucagon (7). The binding potencies of these new analogues relative to glucagon (= 100) are 3.2 (2), 2.9 (3), 10.0 (4), 1.0 (5), 8.5 (6), and 1.7 (7). Analogue 2 is a partial agonist (maximum stimulation of adenylate cyclase (AC) approximately 15% and a potency 8.9% that of glucagon, while the remaining compounds 3-7 are antagonists unable to activate the AC system even at concentrations as high as 10(-5) M. In addition, in competition experiments, analogues 3-7 caused a right-shift of the glucagon stimulated adenylate cyclase dose-response curve.(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
Affiliation(s)
- C Zechel
- Department of Chemistry, University of Arizona, Tucson
| | | | | |
Collapse
|
26
|
Castrucci AM, Hadley ME, Lebl M, Zechel C, Hruby VJ. Melanocyte stimulating hormone and melanin concentration hormone may be structurally and evolutionarily related. Regul Pept 1989; 24:27-35. [PMID: 2544929 DOI: 10.1016/0167-0115(89)90208-5] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Two melanotropic peptides, melanin concentration hormone (MCH) and alpha-melanocyte stimulating hormone (alpha-MSH), exert opposing actions on melanosome (melanin granule) movements within teleost pigment cells, melanocytes (melanophores). MCH stimulates melanosome aggregation to the cell center whereas alpha-MSH stimulates pigment organelle dispersion out into the dendritic processes of the melanocytes. The actions of alpha-MSH are dependent upon extracellular calcium (Ca2+), whereas those of MCH are actually enhanced in the absence of the cation. At high concentrations (10(-5)-10(-8) M) MCH also exhibits MSH-like activity (autoantagonism), an effect which is abolished in the absence of Ca2+. Therefore, MCH exhibits MCH-like as well as MSH-like activity depending on the presence or absence of extracellular Ca2+. An analogue of MCH, [Ala5, Cys10]MCH, has been synthesized which is totally devoid of MCH activity but still exhibits MSH-like activity. These results suggest that the two melanotropic peptides share some component of structural similarity and may be evolutionarily related.
Collapse
Affiliation(s)
- A M Castrucci
- Departamento de Fisiologia Geral, Universidade de São Paulo, Brazil
| | | | | | | | | |
Collapse
|
27
|
Zechel C, Schleenbecker U, Anders A, Pfütz M, Anders F. Search for genes critical for the early and/or late events in carcinogenesis: studies in Xiphophorus (Pisces, Teleostei). Haematol Blood Transfus 1989; 32:366-85. [PMID: 2576236 DOI: 10.1007/978-3-642-74621-5_64] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Southern blot analyses of the xiphophorine genome with probes specific for 15 viral and cellular oncogenes revealed that only three v-erbB related EcoRI fragments comprising 4.9 kb of a certain X, 11.5 kb of another X, and 6.7 kb of both a Y and a Z chromosome are inherited in parallel with the Tu complex and melanoma formation. They are accessory in the genome, and are highly homologous with each other and with an ubiquitous autosomal 7.5-kb fragment. The latter one is probably linked to the indispensable Tu complex that is postulated to be present in all individuals of Xiphophorus irrespective of whether they possess or lack the capacity to form melanoma in interspecific hybrids. Three restriction fragments, the X-chromosomal 4.9-kb, the Y-chromosomal 6.7-kb and the ubiquitous Tu-nonlinked 5.5-kb EcoRI fragments were cloned and sequenced. The X- and the Y-chromosomal fragments show perfect identity in the regions of the putative exons C and D of the EGF receptor gene and minor but significant differences to the putative exon C (exon D not identified) of the Tu-nonlinked fragment of 5.5 kb, indicating that at least two different types of x-erb B genes coding for slightly different EGF-receptors exist in the fish. Northern blot analyses revealed expression of the Tu-linked x-erbB genes (x-gfrB genes) in both transformed and nontransformed tissue, suggesting their essential role in regulation of normal cell proliferation and in carcinogenesis. We conclude that the indispensable x-egfrB genes remain unchanged and strictly regulated, while the sex chromosomal accessory x-egfrB genes possibly undergo dramatic changes in structure and/or function (e.g., unscheduled expression, ectopic expression, point mutations, truncation) leading to activation of the oncogenic potential of these genes, which in turn could induce several cellular events involved in the switch from the normal to the transformed state of the cell. In contrast, none of the x-erbA restriction fragments could be assigned to the Tu-complex or to any regulatory gene (R or S). These results, however, do not exclude the existence of a structural and/or functional relation between x-erbA genes and R and S genes. We therefore analyzed x-erbA genes by cloning, sequencing, and expression studies.(ABSTRACT TRUNCATED AT 400 WORDS)
Collapse
Affiliation(s)
- C Zechel
- Genetisches Institut der Universität Giessen, FRG
| | | | | | | | | |
Collapse
|
28
|
Krstenansky JL, Zechel C, Trivedi D, Hruby VJ. Importance of the C-terminal alpha-helical structure for glucagon's biological activity. Int J Pept Protein Res 1988; 32:468-75. [PMID: 2854536 DOI: 10.1111/j.1399-3011.1988.tb01377.x] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
The synthetic glucagon analogues [Glu21]glucagon, 2, and [Lys17,18,Glu21]glucagon, 3, were designed using Chou-Fasman calculations for the purpose of enhancing the probability for the formation of a C-terminal amphipathic alpha-helical conformation. Circular dichroism indicates increased alpha-helical content for these analogues in solution relative to glucagon. Analogues 2 and 3 also exhibit a 3-fold and 5-fold increase in receptor binding potency, respectively. The adenylate cyclase stimulating potencies of 2 and 3 relative to glucagon are 2.1 and 7 times greater, respectively. Attempts were made at further alpha-helical enhancement by further substitutions in the 10-13 region of glucagon, as represented by the glucagon analogues [Phe13,Lys17,18 Glu21]glucagon, 4, and [Phe10,13,Lys17,18,Glu21]glucagon, 5. These latter substitutions resulted in lowered receptor binding and adenylate cyclase potencies for 4 and 5 relative to 3 despite increased alpha-helical content in solution as observed by circular dichroism spectroscopy.
Collapse
|
29
|
Zechel C, Schleenbecker U, Anders A, Anders F. v-erbB related sequences in Xiphophorus that map to melanoma determining Mendelian loci and overexpress in a melanoma cell line. Oncogene 1988; 3:605-17. [PMID: 2484016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Certain genotypes of Xiphophorus harbour an accessory Mendelian gene which following loss, impairment, or insufficiency of its regulatory genes in the germ line, mediates the hereditary capacity to develop neoplasia spontaneously or following induction with initiating and promoting carcinogens. Together with its linked regulatory genes it forms a 'tumor gene-complex' (Tu-complex). We concentrated on accessory sex chromosomal Tu-complexes that are responsible for sex chromosome-linked melanoma formation. Southern analyses of the xiphophorine genome with 15 authentic oncogene probes revealed so far that only three v-erbB related EcoRI fragments comprising 4.9 kb of a certain X-, 11.5 kb of another X-, and 6.7 kb of both a Y- and Z-chromosome are inherited in parallel with the Tu-complex and melanoma formation. They are accessory in the genome, and are highly homologous with each other. The sequence of the X-chromosomal 4.9 kb fragment shows minor but significant differences to that of the invariably present autosomal xiphophorine erbB (x-erbB) fragment of 5.5 kb, indicating that at least two different x-erbB genes coding for different EGF receptors can exist in the fish. Northern analyses showed expression of both genes in a fibroblast cell line, and overexpression of the sex chromosomal x-erbB in a melanoma cell line. The co-segregation of the hereditary trait of melanoma with the sex chromosomal x-erbB fragments, suggests that the accessory x-erbB gene may be responsible for the switch from the normal to the neoplastic state of the pigment cells.
Collapse
Affiliation(s)
- C Zechel
- Genetisches Institut, Justus-Liebig-Universität Giessen, Federal Republic of Germany
| | | | | | | |
Collapse
|
30
|
Castrucci AM, Hadley ME, Wilkes BC, Zechel C, Hruby VJ. Melanin concentrating hormone exhibits both MSH and MCH activities on individual melanophores. Life Sci 1987; 40:1845-51. [PMID: 3573981 DOI: 10.1016/0024-3205(87)90041-5] [Citation(s) in RCA: 29] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
Asp-Thr-Met-Arg-Cys-Met-Val-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp-Glu-Val (melanin concentrating hormone, MCH) and several fragment analogs (MCH1-14, MCH5-17, MCH5-14) were synthesized and their biological activities determined in a very sensitive fish skin bioassay. The potency ranking and minimum effective doses of the peptides were determined to be: MCH1-17 (10(-12)M) greater than less than MCH5-17 (10(-12)M) greater than MCH1-14 (10(-11)M) greater than MCH5-14 (2 X 10(-10)M). The melanosome aggregating activity of MCH could be completely reversed by a 100-fold higher concentration of pounds-MSH. MCH was self-antagonized in a dose-related manner by higher concentrations of the peptide as was the activity of the MCH1-14 fragment analog. The MCH activities of the MCH5-17 and MCH5-14 analogs were not compromised by even the highest concentrations of the peptides employed. The MSH-like activity of MCH appears to relate to the N-terminus of the peptide whereas MCH activity is more a function of the C-terminus of the hormone. Self-antagonism of MCH at high concentrations appears to relate to the N-terminal tetrapeptide, which is responsible for the intrinsic MSH-like activity of the hormone.
Collapse
|
31
|
Hadley ME, Zechel C, Wilkes BC, Castrucci AM, Visconti MA, Pozo-Alonso M, Hruby VJ. Differential structural requirements for the MSH and MCH activities of melanin concentrating hormone. Life Sci 1987; 40:1139-45. [PMID: 3494178 DOI: 10.1016/0024-3205(87)90231-1] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
H-Asp-Thr-Met-Arg-Cys-Met-Val-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp-Glu-Val-OH , melanin concentrating hormone (MCH), exhibits both melanin granule concentrating and dispersing (MSH-like) activities. Fragment analogues of MCH were synthesized as described herein and the melanotropic activities of the peptides were determined. In the frog (Rana pipiens) and lizard (Anolis carolinensis) skin bioassays, the 5-17 and 5-14 fragments of MCH were inactive (at concentrations of 10(-5)M or less), whereas the 1-14 sequence exhibited minimal (about 10%) MSH-like activity compared to MCH, which, as reported previously, was about 600 times less active than alpha-MSH. In the teleost (fish) skin bioassay, the MCH5-17 analogue was equipotent to MCH, whereas the 1-14 analogue was 10-30 times and the cyclic N- and C- terminal truncated analogue, MCH5-14, was about 300 times less active than MCH. These results suggest that the N-terminal sequence is particularly critical to MSH-like activity in the tetrapod species studied, whereas other structural regions of MCH, particularly in the C-terminal, are more related to MCH activity in teleosts.
Collapse
|